KUALA LUMPUR: The Attorney-General's Chambers (AGC) had to propose amendments to Malaysia's vaccine procurement agreement with Pfizer (Malaysia) Sdn Bhd, after finding clauses which favoured the supplier.
This was revealed in the White Paper on Covid-19 Vaccine Procurement Management released in Parliament on Thursday (June 8).
Already a subscriber? Log in
Save 30% OFF The Star Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
